Literature DB >> 2952153

Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty.

S M Ernst, T A van der Feltz, E T Bal, L van Bogerijen, E van den Berg, C A Ascoop, H W Plokker.   

Abstract

The results of percutaneous transluminal coronary angioplasty were studied in 1352 consecutive patients. The angioplasty procedure was angiographically successful in 1163 (86%) patients and the success rate increased gradually with time. There were no significant differences in success rates in different vessels or indications. The success rate for repeat coronary angioplasty was 92%. In 85% of the patients the clinical course was uncomplicated. Myocardial infarction occurred in 3.6%, emergency coronary bypass grafting in 2.6%, elective bypass surgery in 4.6%, and there were 10 deaths (0.7%). There were 16 deaths (10 non-cardiac) during follow up in the 1163 patients in whom the first procedure was successful. Actuarial analysis showed that after a first angioplasty 77.9% remained free of symptoms and cardiac events for five years and that after a second angioplasty 76% did so. Angiographic follow up showed restenosis in 24% of patients but the overall clinical success rate was 86.2%. On the basis of the intention to treat the procedure was successful in 74.3% of all 1352 patients. Coronary artery bypass surgery was eventually performed in 11.6% of all patients. The long term angiographic success rate of coronary angioplasty is higher than previously suggested.

Entities:  

Mesh:

Year:  1987        PMID: 2952153      PMCID: PMC1216416          DOI: 10.1136/hrt.57.3.220

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

1.  Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  T A Mabin; D R Holmes; H C Smith; R E Vlietstra; G S Reeder; J F Bresnahan; A A Bove; L N Hammes; L R Elveback; T A Orszulak
Journal:  Circulation       Date:  1985-04       Impact factor: 29.690

2.  [Incidence of recurrence after successful transluminal coronary angioplasty].

Authors:  M Kaltenbach; G Kober; A Schmidt-Moritz; D Scherer
Journal:  Dtsch Med Wochenschr       Date:  1983-09-16       Impact factor: 0.628

3.  Repeat coronary angioplasty.

Authors:  B Meier; S B King; A R Gruentzig; J S Douglas; J Hollman; T Ischinger; K Galan; R Tankersley
Journal:  J Am Coll Cardiol       Date:  1984-09       Impact factor: 24.094

4.  Recurrence rate after successful coronary angioplasty.

Authors:  M Kaltenbach; G Kober; D Scherer; C Vallbracht
Journal:  Eur Heart J       Date:  1985-03       Impact factor: 29.983

5.  Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results.

Authors:  J Meyer; H J Schmitz; T Kiesslich; R Erbel; W Krebs; W Schulz; P Bardos; C Minale; B J Messmer; S Effert
Journal:  Am Heart J       Date:  1983-11       Impact factor: 4.749

6.  Emergency coronary angioplasty in refractory unstable angina.

Authors:  P J de Feyter; P W Serruys; M van den Brand; K Balakumaran; B Mochtar; A L Soward; A E Arnold; P G Hugenholtz
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

  6 in total
  4 in total

Review 1.  Restenosis after angioplasty.

Authors:  A H Gershlick; D P de Bono
Journal:  Br Heart J       Date:  1990-12

2.  Percutaneous coronary rotational angioplasty: preliminary clinical and quantitative imaging results.

Authors:  G J Laarman; P W Serruys
Journal:  Int J Card Imaging       Date:  1991

3.  Angioplasty for stable versus unstable angina pectoris: are unstable patients more likely to get restenosis? A quantitative angiographic study in 339 consecutive patients.

Authors:  H E Luijten; K J Beatt; P J de Feyter; M van den Brand; J H Reiber; P W Serruys
Journal:  Int J Card Imaging       Date:  1988

4.  Impact of Dissection after Drug-Coated Balloon Treatment of De Novo Coronary Lesions: Angiographic and Clinical Outcomes.

Authors:  Lin Hui; Eun Seok Shin; Eun Jung Jun; Youngjune Bhak; Scot Garg; Tae Hyun Kim; Chang Bae Sohn; Byung Joo Choi; Liu Kun; Song Lin Yuan; Wang Zhi; Jiang Hao; Shi Zhentao; Tang Qiang
Journal:  Yonsei Med J       Date:  2020-12       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.